×

We've got news for you.

Register on BusinessLIVE at no cost to receive newsletters, read exclusive articles & more.
Register now

Mediclinic has rebuffed a £2bn (R38bn) takeover offer from a group of investors that includes its biggest shareholder, Remgro, with its shares having their best day in about eight months as equity traders bet that the Johann Rupert-chaired investment heavyweight is likely to return with a higher bid.

Along with shipping company MSC, in late May, Remgro offered 463p a share for the 55.4% it does not already own in SA’s most valuable hospital group, which is also listed in London...

BL Premium

This article is reserved for our subscribers.

A subscription helps you enjoy the best of our business content every day along with benefits such as articles from our international business news partners; ProfileData financial data; and digital access to the Sunday Times and Sunday Times Daily.

Already subscribed? Simply sign in below.



Questions or problems? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now